South-East Asia (WHO region) vs United Arab Emirates: Treatment success rate for patients treated for MDR-TB

South-East Asia (WHO region)
77.0%
in 2022
United Arab Emirates
100.0%
in 2022
South-East Asia (WHO region) rank
2nd
United Arab Emirates rank
1st

Treatment success rate for patients treated for MDR-TB over time

  • South-East Asia (WHO region)
  • United Arab Emirates
020406080100200620142022

How they compare

United Arab Emirates currently reports 100.0% against 77.0% in South-East Asia (WHO region), a difference of 23.0%.

That makes United Arab Emirates's figure about 1.3 times South-East Asia (WHO region)'s.

The two have swapped places 2 times across 9 shared years of data; in 2007 it was United Arab Emirates ahead.

South-East Asia (WHO region) ranks 2nd and United Arab Emirates ranks 1st of 11 groups.

Across the 3 decades both report, South-East Asia (WHO region) averaged higher in 1 and United Arab Emirates in 2.

Head to head by decade

Decade South-East Asia (WHO region) United Arab Emirates Difference Ahead
2000s 62.5% 100.0% 37.5% United Arab Emirates
2010s 53.3% 25.0% 28.3% South-East Asia (WHO region)
2020s 77.0% 100.0% 23.0% United Arab Emirates

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment success rate for patients treated for mdr-tb, South-East Asia (WHO region) or United Arab Emirates?
United Arab Emirates, at 100.0% against 77.0% in South-East Asia (WHO region) as of 2022.
What is the difference in treatment success rate for patients treated for mdr-tb between South-East Asia (WHO region) and United Arab Emirates?
23.0%, with United Arab Emirates ahead.
How many years of comparable data are there for South-East Asia (WHO region) and United Arab Emirates?
9 years are reported by both, from 2007 to 2022.
How do South-East Asia (WHO region) and United Arab Emirates rank globally for treatment success rate for patients treated for mdr-tb?
South-East Asia (WHO region) ranks 2nd and United Arab Emirates ranks 1st of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

South-East Asia (WHO region) vs United Arab Emirates: Treatment success rate for patients treated for MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 18 September 2026, from https://health.statizoid.com/compare/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/south-east-asia-who-region/united-arab-emirates/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/south-east-asia-who-region/united-arab-emirates/">South-East Asia (WHO region) vs United Arab Emirates: Treatment success rate for patients treated for MDR-TB</a> — Statizoid

About this data

Indicator
Treatment success rate for patients treated for MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
175 places, 2,495 data points, 1999–2022
Last refreshed